The identification of tumor-infiltrating lymphocytes in patients with stomach cancer
Background. Stomach cancer (SC) is the 6th most common neoplasm among cancers (1 033 701 cases; 5.7%) and the 3rd most deadly cancer worldwide for men and women (782 685 deaths, 8.2%). SC therapy is a complex treatment associated with surgery, adjuvant chemotherapy, targeted therapy and immunotherap...
Guardado en:
Autores principales: | Gulnoz G. Khakimova, Yana A. Bozhchenko, Tatyana N. Zabotina, Alexey A. Tryakin |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/757ada350e4c42cdb0eb49a48a86d7a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
por: Chih-Yang Huang, et al.
Publicado: (2018) -
Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients
por: Jikun Feng, et al.
Publicado: (2021) -
The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer
por: Laura García-Estevez, et al.
Publicado: (2021) -
Gradual Histopathologic Changes During Development of Colorectal Cancer
por: Vahid Nejati, et al.
Publicado: (2019) -
The effect of local immunity on gastric cancer prognosis
por: Gulnoz G. Khakimova, et al.
Publicado: (2020)